Table 4.
Summary of the prognostic significance of long non-coding RNAs in colorectal cancer.
| LncRNAs | Expression | Patient No. | Univariate analysis HR (95%CI) | Multivariate analysis HR (95%CI) | Reference | ||
|---|---|---|---|---|---|---|---|
| OS | PFS/DFS/RFS | OS | PFS/DFS/RFS | ||||
| NEAT1_v1 | Up | 191 | 0.415(0.227–0.758) | NA | NA | NA | [165] |
| NEAT1_v2 | Up | 191 | 0.426(0.231–0.784) | NA | 0.519 (0.280–0.965) | NA | [165] |
| NEAT1 | Up | 239 | 1.88(1.32–2.69) | 1.93(1.38–2.71) | 1.70(1.18–2.45) | 1.80(1.27–2.55) | [184] |
| PVT-1 | Up | 210 | 2.07(1.42–3.06) | 2.01(1.26–2.64) | 1.76(1.16–2.37) | 2.15(1.39–2.76) | [176] |
| HOTTIP | Down | 52 | NA | NA | 4.949(1.685–11.984) | NA | [181] |
| XIST | Up | 196 | 1.284(1.143–1.442) | 1.242(1.115–1.384) | 1.197(1.064–1.346) | 1.165(1.044–1.300) | [173] |
| CCAT1 | Up | 135 | 4.06(1.47–16.8) | 3.88(1.67–8.39) | 5.90(2.09–24.7) | 2.52(1.07–5.56) | [174] |
| CCAT2 | Up | 135 | 2.04(1.05–3.84) | 2.55(1.19–5.31) | 2.40(1.22–4.59) | 2.39(1.10–5.08) | [174] |
| CCAT1+CCAT2 | Up | 135 | NA | NA | 8.38(2.68–37.0) | 2.60(1.04–6.06) | [174] |
| DANCR | Up | 104 | 2.491(1.335–7.264) | 2.614(1.572–7.715) | 2.131(1.157–7.058) | 2.397(1.385–7.279) | [175] |
| SBDSP1 | Up | 171 | 2.673(1.562–5.632) | 2.523(1.429–5.013) | 2.137(1.238–4.672) | 2.132(1.123–4.239) | [177] |
| BANCR | Up | 106 | 2.74(1.52–4.96) | NA | 2.24(1.22–4.16) | NA | [178] |
| UCA1 | Up | 715 | 2.65(1.93–3.63) | NA | 2.39(1.80–3.16) | NA | [179] |
| AFAP1-AS1 | Up | 52 | 2.780(1.308–5.909) | 2.389(1.162–4.913) | 2.358(1.110–5.008) | 2.120(1.032–4.353) | [182][183] |
| NR_029373 | Down | 94 | NA | 0.477(0.261–0.870) | NA | 0.457(0.246–0.848) | [168] |
| NR_034119 | Down | 94 | NA | 0.561(0.316–0.996) | NA | 0.517(0.277–0.964) | [168] |